News

Best Wishes to Verastem in their New Endeavors in Cancer Research

Just today, we learned that Verastem, a biotech company that has previously done research in mesothelioma, has now embarked on several new projects.
In the news, announced in a press release, the company lists several projects, including this one:
Clinical Collaboration with Pfizer and Merck KGaA to Evaluate Combination of VS-6063 and Avelumab in Ovarian Cancer –In March […]


Congress Includes of $50 million for Cancer Research Program

In the latest iteration of its budget bill, Congress included $50 million for the Department of Defense’s (DoD) Peer Reviewed Cancer Research Program (PRCRP). The bill will be voted on in the House on Friday, and in the Senate shortly thereafter.
If the bill does pass, this level of funding will be consistent with funding for […]


Renewal of Zadroga Act Presents Major Win for Mesothelioma Advocates

Today, Congress voted and passed its budget bill, which included a nearly indefinite renewal of the Zadroga Act, which provides heathcare for first responders and others impacted by events of 9/11, the results look promising. The Meso Foundation is hopeful that the bill will pass thus extending nearly indefinitely healthcare benefits to first responders who […]


New Search Tool Allows Easy Navigation of Funded Research Projects

This week, we announced the release of a search tool which will enable users on the Meso Foundation’s website to easily search through nearly 100 mesothelioma research projects the organization has funded since its inception.
“As we continue funding important research, it has become very important to create easy ways to sort through that research,” said […]